Naoero vs Singapore: Immunization, Hib3
Naoero
97.0%
in 2024
Singapore
97.0%
in 2024
Naoero rank
29th
Singapore rank
29th
Immunization, Hib3 over time
- Naoero
- Singapore
How they compare
Naoero currently reports 97.0% against 97.0% in Singapore, a difference of 0.0%.
The two have swapped places 3 times across 12 shared years of data; in 2013 it was Naoero ahead.
Naoero ranks 29th and Singapore ranks 29th of 191 countries.
Singapore has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Naoero | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 91.9% | 93.1% | 1.3% | Singapore |
| 2020s | 96.8% | 97.6% | 0.8% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Naoero or Singapore?
- Naoero, at 97.0% against 97.0% in Singapore as of 2024.
- What is the difference in immunization, hib3 between Naoero and Singapore?
- 0.0%, with Naoero ahead.
- How many years of comparable data are there for Naoero and Singapore?
- 12 years are reported by both, from 2013 to 2024.
- How do Naoero and Singapore rank globally for immunization, hib3?
- Naoero ranks 29th and Singapore ranks 29th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.